|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Venook AP, Weiser MR and Tepper JE:
Colorectal cancer: All hands on deck. Am Soc Clin Oncol Educ Book.
1–89. 2014.
|
|
3
|
de Gramont A, Figer A, Seymour M, Homerin
M, Hmissi A, Cassidy J, Boni C, Cortes-Funes H, Cervantes A, Freyer
G, et al: Leucovorin and fluorouracil with or without oxaliplatin
as first-line treatment in advanced colorectal cancer. J Clin
Oncol. 18:2938–2947. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Douillard JY, Cunningham D, Roth AD,
Navarro M, James RD, Karasek P, Jandik P, Iveson T, Carmichael J,
Alakl M, et al: Irinotecan combined with fluorouracil compared with
fluorouracil alone as first-line treatment for metastatic
colorectal cancer: A multicentre randomised trial. Lancet.
355:1041–1047. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Goldberg RM, Sargent DJ, Morton RF, Fuchs
CS, Ramanathan RK, Williamson SK, Findlay BP, Pitot HC and Alberts
SR: A randomized controlled trial of fluorouracil plus leucovorin,
irinotecan and oxaliplatin combinations in patients with previously
untreated metastatic colorectal cancer. J Clin Oncol. 22:23–30.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tournigand C, André T, Achille E, Lledo G,
Flesh M, Mery-Mignard D, Quinaux E, Couteau C, Buyse M, Ganem G, et
al: FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced
colorectal cancer: A randomized GERCOR study. J Clin Oncol.
22:229–237. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nakagawa T, Tanaka Y, Matsuoka E, Kondo S,
Okada Y, Noda Y, Kanai Y and Hirokawa N: Identification and
classification of 16 new kinesin superfamily (KIF) proteins in
mouse genome. Proc Natl Acad Sci USA. 94:pp. 9654–9659. 1997;
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lawrence CJ, Dawe RK, Christie KR,
Cleveland DW, Dawson SC, Endow SA, Goldstein LS, Goodson HV,
Hirokawa N, Howard J, et al: A standardized kinesin nomenclature. J
Cell Biol. 167:19–22. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Miki H, Okada Y and Hirokawa N: Analysis
of the kinesin superfamily: Insights into structure and function.
Trends Cell Biol. 15:467–476. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wandke C, Barisic M, Sigl R, Rauch V, Wolf
F, Amaro AC, Tan CH, Pereira AJ, Kutay U, Maiato H, et al: Human
chromokinesins promote chromosome congression and spindle
microtubule dynamics during mitosis. J Cell Biol. 198:847–863.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mazumdar M, Sundareshan S and Misteli T:
Human chromokinesin KIF4A functions in chromosome condensation and
segregation. J Cell Biol. 166:613–620. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Narayan G, Bourdon V, Chaganti S,
Arias-Pulido H, Nandula SV, Rao PH, Gissmann L, Dürst M, Schneider
A, Pothuri B, et al: Gene dosage alterations revealed by cDNA
microarray analysis in cervical cancer: Identification of candidate
amplified and overexpressed genes. Genes Chromosomes Cancer.
46:373–384. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Taniwaki M, Takano A, Ishikawa N, Yasui W,
Inai K, Nishimura H, Tsuchiya E, Kohno N, Nakamura Y and Daigo Y:
Activation of KIF4A as a prognostic biomarker and therapeutic
target for lung cancer. Clin Cancer Res. 13:6624–6631. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gao J, Sai N, Wang C, Sheng X, Shao Q,
Zhou C, Shi Y, Sun S, Qu X and Zhu C: Overexpression of
chromokinesin KIF4 inhibits proliferation of human gastric
carcinoma cells both in vitro and in vivo. Tumour Biol. 32:53–61.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Minakawa Y, Kasamatsu A, Koike H, Higo M,
Nakashima D, Kouzu Y, Sakamoto Y, Ogawara K, Shiiba M, Tanzawa H
and Uzawa K: Kinesin family member 4A: A potential predictor for
progression of human oral cancer. PLoS One. 8:e859512013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zou JX, Duan Z, Wang J, Sokolov A, Xu J,
Chen CZ, Li JJ and Chen HW: Kinesin family deregulation coordinated
by bromodomain protein ANCCA and histone methyltransferase MLL for
breast cancer cell growth, survival and tamoxifen resistance. Mol
Cancer Res. 12:539–549. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sobin LH GM and Wittekind CH:
International Union Against Cancer (UICC) TNM Classification of
Malignant Tumors. Oxford, UK: Wiley-Blackwell; 2009
|
|
18
|
Sobin LH and Compton CC: TNM seventh
edition: What's new, what's changed: Communication from the
international union against cancer and the american joint committee
on cancer. Cancer. 116:5336–5339. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Okano M, Kumamoto K, Saito M, Onozawa H,
Saito K, Abe N, Ohtake T and Takenoshita S: Upregulated annexin A1
promotes cellular invasion in triple-negative breast cancer. Oncol
Rep. 33:1064–1070. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang H, Lu C, Li Q, Xie J, Chen T, Tan Y,
Wu C and Jiang J: The role of Kif4A in doxorubicin-induced
apoptosis in breast cancer cells. Mol Cells. 37:812–818. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mazumdar M, Lee JH, Sengupta K, Ried T,
Rane S and Misteli T: Tumor formation via loss of a molecular motor
protein. Curr Biol. 16:1559–1564. 2006. View Article : Google Scholar : PubMed/NCBI
|
